Henrik Lublin

2.7k total citations
59 papers, 2.0k citations indexed

About

Henrik Lublin is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Philosophy. According to data from OpenAlex, Henrik Lublin has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Psychiatry and Mental health, 12 papers in Cellular and Molecular Neuroscience and 11 papers in Philosophy. Recurrent topics in Henrik Lublin's work include Schizophrenia research and treatment (35 papers), Mental Health and Psychiatry (11 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Henrik Lublin is often cited by papers focused on Schizophrenia research and treatment (35 papers), Mental Health and Psychiatry (11 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Henrik Lublin collaborates with scholars based in Denmark, Sweden and United Kingdom. Henrik Lublin's co-authors include Birte Glenthøj, Jimmi Nielsen, David Taylor, Jes Gerlach, Bjørn H. Ebdrup, Egill Rostrup, Hans Rasmussen, Nikolaj Bak, Sanne Wulff and Mette Ødegaard Nielsen and has published in prestigious journals such as American Journal of Psychiatry, Annals of Surgery and Biological Psychiatry.

In The Last Decade

Henrik Lublin

57 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrik Lublin Denmark 25 1.3k 438 392 251 246 59 2.0k
Eduard Parellada Spain 30 1.4k 1.1× 478 1.1× 384 1.0× 180 0.7× 322 1.3× 98 2.5k
Hélio Elkis Brazil 26 1.4k 1.1× 574 1.3× 246 0.6× 146 0.6× 505 2.1× 105 2.2k
Lutz Schmidt Germany 27 1.0k 0.8× 467 1.1× 594 1.5× 170 0.7× 397 1.6× 66 2.4k
M.A. Reveley United Kingdom 20 878 0.7× 431 1.0× 255 0.7× 179 0.7× 190 0.8× 37 1.5k
Henry Silver Israel 26 1.3k 1.0× 593 1.4× 443 1.1× 268 1.1× 458 1.9× 82 2.3k
Paul A. Thompson United States 20 969 0.7× 394 0.9× 338 0.9× 103 0.4× 269 1.1× 32 1.8k
J.A. Lieberman United States 21 1.9k 1.4× 505 1.2× 289 0.7× 209 0.8× 395 1.6× 60 2.5k
Iluminada Corripio Spain 24 923 0.7× 546 1.2× 238 0.6× 185 0.7× 243 1.0× 87 1.7k
Thomas J. Raedler Germany 21 946 0.7× 543 1.2× 667 1.7× 223 0.9× 475 1.9× 46 2.5k
Katherine Beck United Kingdom 20 1.2k 0.9× 357 0.8× 477 1.2× 331 1.3× 238 1.0× 37 2.6k

Countries citing papers authored by Henrik Lublin

Since Specialization
Citations

This map shows the geographic impact of Henrik Lublin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Lublin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Lublin more than expected).

Fields of papers citing papers by Henrik Lublin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Lublin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Lublin. The network helps show where Henrik Lublin may publish in the future.

Co-authorship network of co-authors of Henrik Lublin

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Lublin. A scholar is included among the top collaborators of Henrik Lublin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Lublin. Henrik Lublin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nielsen, Mette Ødegaard, Egill Rostrup, Sanne Wulff, et al.. (2012). Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients. Biological Psychiatry. 71(10). 898–905. 170 indexed citations
2.
Nielsen, Jimmi, Charlotte Emborg, Susanne Gydesen, et al.. (2012). Augmenting Clozapine With Sertindole. Journal of Clinical Psychopharmacology. 32(2). 173–178. 32 indexed citations
3.
Ebdrup, Bjørn H., Filip K. Knop, Pelle L. Ishøy, et al.. (2012). Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits. BMC Medicine. 10(1). 92–92. 27 indexed citations
4.
Baandrup, Lone, Peter Allerup, Henrik Lublin, et al.. (2010). Evaluation of a multifaceted intervention to limit excessive antipsychotic co‐prescribing in schizophrenia out‐patients. Acta Psychiatrica Scandinavica. 122(5). 367–374. 35 indexed citations
5.
Baandrup, Lone, Peter Allerup, Merete Nordentoft, Henrik Lublin, & Birte Glenthøj. (2010). Exploring Regional Variation in Antipsychotic Coprescribing Practice. The Journal of Clinical Psychiatry. 71(11). 1457–1464. 10 indexed citations
6.
Nielsen, Jimmi, et al.. (2009). Psychiatrists’ attitude towards and knowledge of clozapine treatment. Journal of Psychopharmacology. 24(7). 965–971. 163 indexed citations
7.
Hansen, Thomas Folkmann, Klaus D. Jakobsen, Mogens Fenger, et al.. (2008). Variation in the purinergic P2RX7 receptor gene and schizophrenia. Schizophrenia Research. 104(1-3). 146–152. 22 indexed citations
8.
Nielsen, Jimmi, Povl Munk‐Jørgensen, Per Damkier, Henrik Lublin, & David Taylor. (2007). Augmenting clozapine with sertindole (SERCLOZ) - A double blind study. 1 indexed citations
9.
Wolf, Jürgen, Henrik Lublin, Raimo K. R. Salokangas, et al.. (2007). A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA). Current Medical Research and Opinion. 23(10). 2313–2323. 23 indexed citations
10.
Poulsen, Henrik Day, et al.. (2005). Drug therapy of dementia in elderly patients. A review. Nordic Journal of Psychiatry. 59(2). 71–77. 15 indexed citations
11.
Lublin, Henrik, et al.. (2003). Long‐term effectiveness of risperidone and olanzapine in resistant or intolerant schizophrenic patients. A mirror study. Acta Psychiatrica Scandinavica. 107(5). 344–350. 14 indexed citations
12.
Lublin, Henrik, et al.. (2002). [Diagnosis and treatment of depression in general practice. A questionnaire study].. PubMed. 164(26). 3440–4. 2 indexed citations
13.
Lindström, Eva, Tommy Lewander, Ulf Malm, et al.. (2001). Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nordic Journal of Psychiatry. 55(sup44). 5–69. 28 indexed citations
14.
Lindström, Eva, Tommy Lewander, Ulf Malm, et al.. (2001). Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia: Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nordic Journal of Psychiatry. 55(5). 5–69. 94 indexed citations
15.
Peacock, L, Henrik Lublin, Jes Gerlach, & Torfinn Solgaard. (1996). Clozapine versus typical antipsychotics a retro- and prospective study of extrapyramidal side effects. Psychopharmacology. 124(1-2). 188–196. 58 indexed citations
16.
Lublin, Henrik. (1995). Dopamine Receptor Agonist- and Antagonist-Induced Behaviors in Primates Previously Treated with Dopamine Receptor Antagonists. Clinical Neuropharmacology. 18(6). 533–552. 10 indexed citations
17.
Lublin, Henrik, Jes Gerlach, & Linda Peacock. (1992). Effect of D1 and D2 Agonists in Primates Withdrawn from Long-Term Treatment with Haloperidol. Clinical Neuropharmacology. 15(6). 448–458. 19 indexed citations
18.
Lublin, Henrik, et al.. (1991). Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia. European Neuropsychopharmacology. 1(4). 541–548. 18 indexed citations
19.
Peacock, Linda, Henrik Lublin, & Jes Gerlach. (1990). The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment. European Journal of Pharmacology. 186(1). 49–59. 44 indexed citations
20.
Lublin, Henrik & Jes Gerlach. (1988). Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol. European Journal of Pharmacology. 153(2-3). 239–245. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduard Parellada Breakdown of academic impact, for papers by Hélio Elkis Breakdown of academic impact, for papers by Lutz Schmidt Breakdown of academic impact, for papers by M.A. Reveley Breakdown of academic impact, for papers by Henry Silver Breakdown of academic impact, for papers by Paul A. Thompson Breakdown of academic impact, for papers by J.A. Lieberman Breakdown of academic impact, for papers by Iluminada Corripio Breakdown of academic impact, for papers by Thomas J. Raedler Breakdown of academic impact, for papers by Katherine Beck
Rankless by CCL
2026